Javier Rueda-Gotor1, Javier Llorca2, Alfonso Corrales1, Ricardo Blanco1, Patricia Fuentevilla1, Virginia Portilla1, Rosa Expósito3, Cristina Mata3, Trinitario Pina1, Carlos González-Juanatey4, Miguel A González-Gay5. 1. Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, IDIVAL, University of Cantabria, Santander, Spain. 2. Division of Epidemiology and Computational Biology, School of Medicine, University of Cantabria, Santander, and CIBER Epidemiología y Salud Pública (CIBERESP), Spain. 3. Division of Rheumatology, Hospital Comarcal, Laredo, Cantabria, Spain. 4. Division of Cardiology, Hospital Lucus Augusti, Lugo, Spain. 5. Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, IDIVAL, University of Cantabria, Santander, Spain. miguelaggay@hotmail.com.
Abstract
OBJECTIVES: To determine if the use of carotid ultrasonography (US) may improve the cardiovascular (CV) risk stratification in patients with ankylosing spondylitis (AS). METHODS: A set of 127 consecutive patients without history of CV events, diabetes mellitus or chronic kidney disease that fulfilled definitions for AS according to the 1984 modified New York criteria were recruited to assess carotid intima-media thickness and presence of plaques. CV risk was calculated according to the systematic coronary risk evaluation (SCORE), the Framingham Risk Score (FRS) and the Reynolds Risk Score (RRS). RESULTS: Men outnumbered women (61.4%). The mean±SD age at the time of the study was 44.5±11.6 years. The median (interquartile range-IQR) disease duration was 13 (7-22) years. The median (IQR) BASDAI at the time of the study was 3.65 (1.7- 4.9). HLA-B-27 was positive in 77.2%, and syndesmophytes were present in 38.9%. Carotid plaques were found in 43 (33.9%). Regardless of the algorithm used for CV risk stratification, more than 50% of the patients classified as having moderate CV risk had carotid plaques. Moreover, 20.8%, 24.6% and 53.3% of AS that fulfilled the category of low CV risk according to the total cholesterol (TC)-SCORE, FRS and RRS, respectively had carotid plaques. A model that included patients with a chart TC-SCORE ≥5% or TC-SCORE ≥1% <5% plus carotid plaques or TC-SCORE <1% and CRP >3 mg/L at diagnosis plus syndesmophytes and carotid plaques or TC-SCORE <1% and CRP >3 mg/L at diagnosis plus extraarticular manifestations plus carotid plaques yielded the highest sensitivity (93.0%) for high/very high CV risk in these patients. The presence of syndesmophytes was associated with increased risk of carotid plaques in AS that fulfilled definitions for low CV risk according to the TC-SCORE (OR 8.75 [95% CI 2.11-36.40]; p=0.002). CONCLUSIONS: Our results support the use of carotid US in the assessment of CV risk in patients with AS.
OBJECTIVES: To determine if the use of carotid ultrasonography (US) may improve the cardiovascular (CV) risk stratification in patients with ankylosing spondylitis (AS). METHODS: A set of 127 consecutive patients without history of CV events, diabetes mellitus or chronic kidney disease that fulfilled definitions for AS according to the 1984 modified New York criteria were recruited to assess carotid intima-media thickness and presence of plaques. CV risk was calculated according to the systematic coronary risk evaluation (SCORE), the Framingham Risk Score (FRS) and the Reynolds Risk Score (RRS). RESULTS:Men outnumbered women (61.4%). The mean±SD age at the time of the study was 44.5±11.6 years. The median (interquartile range-IQR) disease duration was 13 (7-22) years. The median (IQR) BASDAI at the time of the study was 3.65 (1.7- 4.9). HLA-B-27 was positive in 77.2%, and syndesmophytes were present in 38.9%. Carotid plaques were found in 43 (33.9%). Regardless of the algorithm used for CV risk stratification, more than 50% of the patients classified as having moderate CV risk had carotid plaques. Moreover, 20.8%, 24.6% and 53.3% of AS that fulfilled the category of low CV risk according to the total cholesterol (TC)-SCORE, FRS and RRS, respectively had carotid plaques. A model that included patients with a chart TC-SCORE ≥5% or TC-SCORE ≥1% <5% plus carotid plaques or TC-SCORE <1% and CRP >3 mg/L at diagnosis plus syndesmophytes and carotid plaques or TC-SCORE <1% and CRP >3 mg/L at diagnosis plus extraarticular manifestations plus carotid plaques yielded the highest sensitivity (93.0%) for high/very high CV risk in these patients. The presence of syndesmophytes was associated with increased risk of carotid plaques in AS that fulfilled definitions for low CV risk according to the TC-SCORE (OR 8.75 [95% CI 2.11-36.40]; p=0.002). CONCLUSIONS: Our results support the use of carotid US in the assessment of CV risk in patients with AS.
Authors: Edit Végh; György Kerekes; Anita Pusztai; Attila Hamar; Szilvia Szamosi; Andrea Váncsa; Levente Bodoki; Lilla Pogácsás; Fruzsina Balázs; Katalin Hodosi; Andrea Domján; Sándor Szántó; Zoltán Nagy; Zoltán Szekanecz; Gabriella Szűcs Journal: Rheumatol Int Date: 2019-12-17 Impact factor: 2.631
Authors: Marcos A González-López; Marina Lacalle; Cristina Mata; María López-Escobar; Alfonso Corrales; Raquel López-Mejías; Javier Rueda; M Carmen González-Vela; Miguel A González-Gay; Ricardo Blanco; José L Hernández Journal: PLoS One Date: 2018-01-04 Impact factor: 3.240
Authors: Javier Rueda-Gotor; Fernanda Genre; Alfonso Corrales; Ricardo Blanco; Patricia Fuentevilla; Virginia Portilla; Rosa Expósito; Cristina Mata Arnaiz; Trinitario Pina; Carlos González-Juanatey; Luis Rodriguez-Rodriguez; Miguel A González-Gay Journal: Int J Rheumatol Date: 2018-02-15
Authors: Fernanda Genre; Javier Rueda-Gotor; Sara Remuzgo-Martínez; Alfonso Corrales; Verónica Mijares; Rosa Expósito; Cristina Mata; Virginia Portilla; Ricardo Blanco; José Luis Hernández; Javier Llorca; Oreste Gualillo; Raquel López-Mejías; Miguel A González-Gay Journal: Sci Rep Date: 2018-09-13 Impact factor: 4.379
Authors: Enrico Maria Zardi; Maria Elena Pipita; Chiara Giorgi; Domenico Lichinchi; Domenico Maria Zardi; Antonella Afeltra Journal: Medicine (Baltimore) Date: 2018-07 Impact factor: 1.889
Authors: María Lourdes Ladehesa-Pineda; Iván Arias de la Rosa; Clementina López Medina; María Del Carmen Castro-Villegas; María Del Carmen Ábalos-Aguilera; Rafaela Ortega-Castro; Ignacio Gómez-García; Pedro Seguí-Azpilcueta; Yolanda Jiménez-Gómez; Alejandro Escudero-Contreras; Chary López Pedrera; Nuria Barbarroja; Eduardo Collantes-Estévez Journal: Ther Adv Musculoskelet Dis Date: 2020-12-30 Impact factor: 5.346